Alcentra Capital - ABDC Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00
+0 (0.00%)
Get New Alcentra Capital Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ABDC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ABDC

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Alcentra Capital in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for ABDC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Alcentra Capital. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/13/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/8/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/8/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/15/2018Keefe, Bruyette & WoodsSet TargetHold$7.00High
1/11/2018Raymond JamesUpgradeUnderperform ➝ Market PerformHigh
1/11/2018UBS GroupUpgradeUnderperform ➝ Market PerformHigh
11/10/2017Keefe, Bruyette & WoodsReiterated RatingHold$9.50N/A
11/8/2017Raymond JamesDowngradeOutperform ➝ UnderperformN/A
11/8/2017RoweDowngradeOutperform ➝ UnderperformN/A
11/8/2017UBS GroupDowngradeOutperform ➝ UnderperformN/A
(Data available from 10/5/2017 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/9/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/8/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/8/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/6/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/5/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/5/2022

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Alcentra Capital logo
Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector. It focuses on investment opportunities headquartered in the United States. The fund seeks to invest $5 million to $15 million per transaction in companies with EBITDA between $5 million to $15 million and revenues of between $10 million and $100 million. It invests in the form of subordinated debt and, to a lesser extent, senior debt and minority equity investments.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $8.90
Low: $8.90
High: $8.90

52 Week Range

Now: N/A

Volume

241,414 shs

Average Volume

39,252 shs

Market Capitalization

$114.60 million

P/E Ratio

8.81

Dividend Yield

8.09%

Beta

0.57

Frequently Asked Questions

What sell-side analysts currently cover shares of Alcentra Capital?

The following Wall Street analysts have issued research reports on Alcentra Capital in the last twelve months:
View the latest analyst ratings for ABDC.

What is the current price target for Alcentra Capital?

0 Wall Street analysts have set twelve-month price targets for Alcentra Capital in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Alcentra Capital in the next year.
View the latest price targets for ABDC.

What is the current consensus analyst rating for Alcentra Capital?

Alcentra Capital currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ABDC.

What other companies compete with Alcentra Capital?

How do I contact Alcentra Capital's investor relations team?

Alcentra Capital's physical mailing address is 200 PARK AVENUE 7TH FLOOR, NEW YORK NY, 10166. The asset manager's listed phone number is 212-922-8240 and its investor relations email address is [email protected] The official website for Alcentra Capital is www.alcentracapital.com. Learn More about contacing Alcentra Capital investor relations.